Heritage Cannabis’s methodical approach to expansion continues to serve them well
Heritage Cannabis (CSE: CANN) President and CEO Clint Sharples joined Steve Darling from Proactive to update a number of moves the company has made. Those include teaming up with Patient Choice and acquiring Opticann.
Sharples talks about those deals and he also offers some thoughts on CannaCure getting a sales licence from Health Canada and when the company may have products in stores right across Canada.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Heritage Cannabis Holdings Corp. named herein, including the promotion by the Company of Heritage Cannabis Holdings Corp. in any Content on the...FOR OUR FULL DISCLAIMER CLICK HERE